Further functional studies revealed that silencing PLA2G7 expression produced antiproliferative, proapoptotic, and antimigratory effects on prostate cancer cells and that statin treatment combined with PLA2G7 silencing synergistically exerted an antiproliferative effect.197 Recently, Alinezhad et al198 also identified PLA2G7 as a valid biomarker for prostate cancer and subsequently evaluated its functions in disease‐relevant processes. Here, PLA2G7 is linked to prostate cancer.